A benefit-cost analysis of different response scenarios to COVID-19: A case study

被引:2
|
作者
Cook, David C. [1 ,2 ]
Fraser, Rob W. [1 ,3 ]
McKirdy, Simon J. [2 ]
机构
[1] Univ Western Australia, Sch Agr & Environm, 35 Stirling Highway, Perth, WA 6009, Australia
[2] Murdoch Univ, Harry Butler Res Inst, Perth, WA, Australia
[3] Univ Kent, Dept Econ, Canterbury, Kent, England
关键词
natural disaster; policy making; public policy; simulation modeling; HOSPITAL-CARE; MATHEMATICAL-THEORY; HERD-IMMUNITY; MENTAL-HEALTH; HOME; RISK; TRANSMISSION; DISEASE; LIFE;
D O I
10.1002/hsr2.286
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background This paper compares the direct benefits to the State of Western Australia from employing a "suppression" policy response to the COVID-19 pandemic rather than a "herd immunity" approach. Methods An S-I-R (susceptible-infectious-resolved) model is used to estimate the likely benefits of a suppression COVID-19 response compared to a herd immunity alternative. Direct impacts of the virus are calculated on the basis of sick leave, hospitalizations, and fatalities, while indirect impacts related to response actions are excluded. Results Preliminary modeling indicates that approximately 1700 vulnerable person deaths are likely to have been prevented over 1 year from adopting a suppression response rather than a herd immunity response, and approximately 4500 hospitalizations. These benefits are valued at around AUD4.7 billion. If a do nothing policy had been adopted, the number of people in need of hospitalization is likely to have overwhelmed the hospital system within 50 days of the virus being introduced. Maximum hospital capacity is unlikely to be reached in either a suppression policy or a herd immunity policy. Conclusion Using early international estimates to represent the negative impact each type of policy response is likely to have on gross state product, results suggest the benefit-cost ratio for the suppression policy is slightly higher than that of the herd immunity policy, but both benefit-cost ratios are less than one.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] COVID-19 Vaccination Scenarios: A Cost-Effectiveness Analysis for Turkey
    Hagens, Arnold
    Inkaya, Ahmet Cagkan
    Yildirak, Kasirga
    Sancar, Mesut
    van der Schans, Jurjen
    Sancar, Aylin Acar
    Unal, Serhat
    Postma, Maarten
    Yegenoglu, Selen
    VACCINES, 2021, 9 (04)
  • [32] BENEFIT-COST ANALYSIS OF FAMILY PLANNING
    BLUMSTEIN, A
    CASSIDY, RG
    SOCIO-ECONOMIC PLANNING SCIENCES, 1973, 7 (02) : 151 - 160
  • [33] Performance Bond Benefit-Cost Analysis
    Myers, Lorena
    Najafi, Fazil T.
    TRANSPORTATION RESEARCH RECORD, 2011, (2228) : 3 - 10
  • [34] Notes on cost benefit of COVID-19 lockdown
    Mills, Michael
    Allen, Mary Beth
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2020, 21 (07): : 4 - 6
  • [35] IMPROVING ACCURACY OF BENEFIT-COST ANALYSIS
    BORDMAN, SL
    IEEE SPECTRUM, 1973, 10 (09) : 72 - 76
  • [36] How (Not) to Lie with Benefit-Cost Analysis
    Farrow, Scott
    ECONOMISTS VOICE, 2013, 10 (01): : 45 - 50
  • [37] Dynamic benefit-cost analysis for controlling perennial pepperweed (Lepidium latifolium):: A case study
    Eiswerth, ME
    Singletary, L
    Zimmerman, JR
    Johnson, WS
    WEED TECHNOLOGY, 2005, 19 (02) : 237 - 243
  • [38] Principles and Standards for Benefit-Cost Analysis
    Kumru, Cagri S.
    AUSTRALIAN JOURNAL OF AGRICULTURAL AND RESOURCE ECONOMICS, 2014, 58 (04) : 622 - 624
  • [39] Benefit-Cost Analysis of Increased Trade: An Order-of-Magnitude Estimate of the Benefit-Cost Ratio
    Feyrer, James
    Tyazhelnikov, Vladimir
    Aleman-Castilla, Benjamin
    Wong, Brad
    JOURNAL OF BENEFIT-COST ANALYSIS, 2023, 14 : 108 - 135
  • [40] CONVENTION AND LIMITATION IN BENEFIT-COST ANALYSIS
    HAMMOND, RJ
    NATURAL RESOURCES JOURNAL, 1966, 6 (02) : 195 - 222